Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis (NCT07420751) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Assessment of Patient Experience With Auto-Captioning Glasses in NF2-Related-Schwannomatosis
United States18 participantsStarted 2026-02-19
Plain-language summary
The goal of this clinical trial is to investigate the usability of auto-captioning glasses for adults diagnosed with NF2-related schwannomatosis and loss of hearing. The primary objective of the study is to determine the feasibility and acceptability of auto-captioning glasses in this population.
Participants will be asked to:
* Use the glasses at their discretion for 12 weeks
* Report their feedback at 3 and 12 week timepoints via online surveys and remote qualitative interviews
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of NF2-SWN by 2022 revised criteria
* Age 18 years or older at time of consent
* Willing and able to sign informed consent
* Access to a mobile phone with current operating software (i.e., iOS 16+ or Android 12+) and an internet connection
* Does not require prescription glasses to communicate others (e.g. may use reading glasses or similar)
* Resident of the U.S.
* English-speaking
Exclusion Criteria:
* Current use of auto-captioning glasses
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1This trial is testing auto-captioning glasses as a communication aid for people with NF2-related Schwannomatosis — can you help me understand whether this kind of device might address the hearing challenges I'm facing, and whether it's worth discussing even if I can't join this particular study?
2The trial is no longer actively recruiting — are there any similar studies looking at assistive technology for hearing loss in NF2-related Schwannomatosis that I might still be able to participate in?
3The main thing this study is measuring is a 'System Usability Scale,' which seems to focus on how easy the glasses are to use rather than whether they improve health outcomes — does that mean this is more of an early-stage usability study, and what would that tell us about whether the technology is ready for real-world use?
4Since this trial is rated Phase NA, which often means it's more of a device or feasibility study than a traditional drug trial, what does that mean for how much we'd learn about safety and longer-term benefit from the results?
5Are there any standard-of-care assistive hearing or communication tools you'd recommend I explore now, while research like this is still ongoing?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.